Skip to content
Screener

Surgery Partners, Inc. SGRY EPS (Diluted)

EPS (Diluted) at other companies

Tenet Healthcare logo
Tenet HealthcareTHC
$9.84+213%
UnitedHealth Group logo
UnitedHealth GroupUNH
$6.04+61.5%
Encompass Health Corporation logo
Encompass Health CorporationEHC
$1.93+30.4%
HCA Healthcare logo
HCA HealthcareHCA
$7.62+11.6%
ARD
Ardent Health PartnersARDT
$0.12-76.9%
Astrana Health logo
Astrana HealthASTH
$0.29+107%

Other financials

Income statement

See full
Revenue$848.9M+2.7%
Operating income$102.1M-8.6%
Net income-$15.0M-500%

Balance sheet

See full
Cash & equivalents$216.7M-13.4%
Total debt$5.1B+3.9%
Total equity$1.7B-4.4%
Total assets$8.0B+1.2%

Cash flow

See full
Operating cash flow$59.3M-27.1%
CapEx$21.8M-6.8%
Free cash flow$37.5M-35.2%

Valuation

See full
Market cap$1.73B-36.3%
Enterprise value$6.6B-10.8%
P/S0.5×-0.3×

Profitability

See full
Gross margin23.1%—
Operating margin11.4%+0.2pp
Net margin-2.6%-0.9pp
FCF margin5.6%+0.2pp

Returns & leverage

See full
Return on equity-5.2%-1.7pp
Debt / equity3×+0.2×
Current ratio1.9×0.0×

Where this comes from

Reported directly by Surgery Partners, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: Surgery Partners, Inc.’s 10-Q, filed August 10, 2026.

Filed
Aug 10, 2026, 4:14 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001638833-26-000077
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Less: Net income attributable to non-controlling interests(44.7)(47.4)(78.5)(84.8)
Net income (loss) attributable to Surgery Partners, Inc.$(15.0)$(2.5)$(50.9)$(40.2)
Net income (loss) per share attributable to common stockholders:
Basic$(0.12)$(0.02)$(0.40)$(0.32)
Diluted (1)$(0.12)$(0.02)$(0.40)$(0.32)
Weighted average common shares outstanding:
Basic128,825126,980128,597126,792
Diluted (1)128,825126,980128,597126,792

Item 1. Financial Statements

FAQ

What is Surgery Partners, Inc.'s EPS (diluted)?
Surgery Partners, Inc. (SGRY) reported EPS (diluted) of -$0.12 in Q2 2026.
How has Surgery Partners, Inc.'s EPS (diluted) changed year-over-year?
Surgery Partners, Inc.'s EPS (diluted) decreased by 500.0% year-over-year, from -$0.02 to -$0.12.
What is the long-term trend for Surgery Partners, Inc.'s EPS (diluted)?
Over 3 years (2022 to 2025), Surgery Partners, Inc.'s EPS (diluted) has grown at a 1.1% compound annual growth rate (CAGR), from -$0.59 to -$0.61.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about Surgery Partners, Inc.'s eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude